BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2784941)

  • 1. Response of neoplasms of B cell lineage to the proliferative effects of B cell growth factor and the phorbol ester TPA.
    Kinney MC; Collins RD; Whitlock J; Cousar JB; Vogler LB
    Am J Pathol; 1989 Apr; 134(4):913-23. PubMed ID: 2784941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
    Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J
    Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
    Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
    J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
    Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
    Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis.
    Carlsson M; Matsson P; Rosén A; Sundström C; Tötterman TH; Nilsson K
    Leukemia; 1988 Nov; 2(11):734-44. PubMed ID: 3263557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotypes of leukemic cells from chronic B cell leukemia and their proliferative responses to several kinds of mitogens or lymphokines: PHA or phorbol ester (TPA) induces a high responsibility to B cell growth factor (BCGF) in the leukemic cells].
    Takeuchi H
    Rinsho Ketsueki; 1988 Dec; 29(12):2241-9. PubMed ID: 3266763
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on leukemic cells from chronic B cell leukemia.
    Tokumine Y; Waki K; Nishimori Y; Kuratsune H; Inoue R; Nakamura Y; Ueda E; Machii T; Kitani T
    Leukemia; 1989 Jul; 3(7):516-21. PubMed ID: 2786598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of surface marker changes and monoclonal idiotypic immunoglobulin secretion in lymphoma/leukemia cells: comparative study with interleukin-1, interleukin-2, interleukin-4, 8-bromo-guanosine, pokeweed mitogen, and tetradecanoyl phorbol-13-acetate.
    Gazitt Y; Gangavalli A; Thurman GB
    Mol Biother; 1989; 1(6):297-304. PubMed ID: 2610949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
    Carlsson M; Tötterman TH; Rosén A; Nilsson K
    Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation.
    Gazitt Y; Polliack A
    Blood Cells; 1987; 12(2):413-39. PubMed ID: 3497682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
    Karray S; Emilie D; Galanaud P
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
    Engel P; Inglés J; de la Calle O; Gallart T
    Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets.
    Beiske K; Clark EA; Holte H; Ledbetter JA; Smeland EB; Godal T
    Int J Cancer; 1988 Oct; 42(4):521-8. PubMed ID: 2459071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia.
    Fournier S; Jackson J; Kumar A; King T; Sharma S; Biron G; Rubio M; Delespesse G; Sarfati M
    Eur J Immunol; 1992 Jul; 22(7):1927-30. PubMed ID: 1623931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
    Suzuki T; Butler JL; Cooper MD
    J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of colony-stimulating factors, interleukins, interferons, and tumor necrosis factor on the growth and differentiation of cultured Reed-Sternberg cells. Comparison with effects of phorbol ester and retinoic acid.
    Hsu SM; Hsu PL
    Am J Pathol; 1990 Jan; 136(1):181-9. PubMed ID: 1688689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large granular lymphocytes from B-chronic lymphocytic leukemia patients inhibit normal B cell proliferation.
    Perri RT; Kay NE
    Am J Hematol; 1989 Jul; 31(3):166-72. PubMed ID: 2500849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of human B cell proliferation and differentiation by the combination of phorbol ester and ionomycin.
    Roifman CM; Benedict SH; Cheung RK; Gelfand EW
    Eur J Immunol; 1987 May; 17(5):701-6. PubMed ID: 3495445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
    Hivroz C; Grillot-Courvalin C; Labaume S; Miglierina R; Brouet JC
    Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
    Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
    Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.